SEER
Price:
$1.64
Market Cap:
$100.74M
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk ...[Read more]
Industry
Biotechnology
IPO Date
2020-12-04
Stock Exchange
NASDAQ
Ticker
SEER
According to Seer, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.28. This represents a change of -15.75% compared to the average of -1.52 of the last 4 quarters.
The mean historical PE Ratio of Seer, Inc. over the last ten years is -90.31. The current -1.28 PE Ratio has changed 41.73% with respect to the historical average. Over the past ten years (40 quarters), SEER's PE Ratio was at its highest in in the June 2024 quarter at -1.19. The PE Ratio was at its lowest in in the September 2020 quarter at -100.23.
Average
-90.31
Median
-64.97
Minimum
-214.36
Maximum
-1.44
Discovering the peaks and valleys of Seer, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 11.61%
Maximum Annual PE Ratio = -1.44
Minimum Annual Increase = -81.56%
Minimum Annual PE Ratio = -214.36
Year | PE Ratio | Change |
---|---|---|
2023 | -1.44 | -64.83% |
2022 | -4.08 | -79.82% |
2021 | -20.23 | -81.56% |
2020 | -109.71 | -48.82% |
2019 | -214.36 | 11.61% |
The current PE Ratio of Seer, Inc. (SEER) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-8.58
5-year avg
-69.96
10-year avg
-90.31
Seer, Inc.’s PE Ratio is greater than ORIC Pharmaceuticals, Inc. (-6.13), greater than Anebulo Pharmaceuticals, Inc. (-4.99), greater than Cullinan Oncology, Inc. (-6.96), greater than C4 Therapeutics, Inc. (-3.44), greater than Molecular Partners AG (-2.67), greater than Mineralys Therapeutics, Inc. (-4.63), less than AN2 Therapeutics, Inc. (-0.47), greater than Pharvaris N.V. (-8.20), greater than PepGen Inc. (-3.22), greater than Foghorn Therapeutics Inc. (-4.49), greater than Shattuck Labs, Inc. (-2.08), greater than Monte Rosa Therapeutics, Inc. (-3.11), greater than Kymera Therapeutics, Inc. (-21.01), greater than Nurix Therapeutics, Inc. (-8.82), greater than Quantum-Si incorporated (-1.45), less than HCW Biologics Inc. (-0.69), greater than MediciNova, Inc. (-12.61), greater than Nkarta, Inc. (-3.62), greater than Lyell Immunopharma, Inc. (-1.42), less than Generation Bio Co. (-0.92), greater than Sana Biotechnology, Inc. (-4.82),
Company | PE Ratio | Market cap |
---|---|---|
-6.13 | $680.74M | |
-4.99 | $46.68M | |
-6.96 | $1.04B | |
-3.44 | $374.42M | |
-2.67 | $182.90M | |
-4.63 | $558.43M | |
-0.47 | $30.44M | |
-8.20 | $1.03B | |
-3.22 | $287.77M | |
-4.49 | $416.63M | |
-2.08 | $167.05M | |
-3.11 | $349.21M | |
-21.01 | $2.89B | |
-8.82 | $1.50B | |
-1.45 | $129.66M | |
-0.69 | $26.62M | |
-12.61 | $103.00M | |
-3.62 | $375.37M | |
-1.42 | $299.52M | |
-0.92 | $145.50M | |
-4.82 | $1.12B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Seer, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Seer, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Seer, Inc.'s PE Ratio?
How is the PE Ratio calculated for Seer, Inc. (SEER)?
What is the highest PE Ratio for Seer, Inc. (SEER)?
What is the 3-year average PE Ratio for Seer, Inc. (SEER)?
What is the 5-year average PE Ratio for Seer, Inc. (SEER)?
How does the current PE Ratio for Seer, Inc. (SEER) compare to its historical average?